ACC.26 advanced registration ends Feb. 12 – register now!

Jonathan M. Kalman, MBBS, PhD

General Statement of Disclosure:

RESEARCH/RESEARCH GRANTS: Biosense Webster(SIGNIFICANT), Boston Scientific(SIGNIFICANT), Medtronic inc(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), EBR Systems(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Biosense Webster(NONE), Medtronic(NONE)

View Full Disclosure